AstraZeneca PLC

AstraZeneca PLCverified

AZN

Price:

$183.6

Market Cap:

$287.04B

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty ca...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1993-05-12

Stock Exchange

NYSE

Ticker

AZN

The Enterprise Value as of March 2026 (TTM) for AstraZeneca PLC (AZN) is 310.95B

According to AstraZeneca PLC’s latest financial reports and current stock price. The company's current Enterprise Value is 310.95B. This represents a change of 16.92% compared to the average of 265.95B of the last 4 quarters.

AstraZeneca PLC (AZN) Historical Enterprise Value (quarterly & annually)

How has AZN Enterprise Value performed in the past?

The mean historical Enterprise Value of AstraZeneca PLC over the last ten years is 177.64B. The current 310.95B Enterprise Value has changed 17.40% with respect to the historical average. Over the past ten years (40 quarters), AZN's Enterprise Value was at its highest in in the December 2025 quarter at 311.70B. The Enterprise Value was at its lowest in in the December 2016 quarter at 81.04B.

Quarterly (TTM)
Annual

Average

177.64B

Median

167.45B

Minimum

81.09B

Maximum

311.51B

AstraZeneca PLC (AZN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AstraZeneca PLC Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 36.85%

Maximum Annual Enterprise Value = 311.51B

Minimum Annual Increase = -14.54%

Minimum Annual Enterprise Value = 81.09B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025311.51B36.85%
2024227.63B-2.47%
2023233.39B0.23%
2022232.85B21.97%
2021190.91B32.75%
2020143.81B-0.13%
2019143.99B31.91%
2018109.16B6.96%
2017102.05B25.85%
201681.09B-14.54%

AstraZeneca PLC (AZN) Average Enterprise Value

How has AZN Enterprise Value performed in the past?

The current Enterprise Value of AstraZeneca PLC (AZN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

257.51B

5-year avg

239.26B

10-year avg

177.64B

AstraZeneca PLC (AZN) Enterprise Value vs. Peers

How is AZN’s Enterprise Value compared to its peers?

AstraZeneca PLC’s Enterprise Value is greater than Novartis AG (305.10B), greater than GSK plc (92.40B), greater than Roche Holding AG (265.57B), greater than Bristol-Myers Squibb Company (153.99B), greater than Sanofi (107.73B), less than Merck & Co., Inc. (318.27B), greater than Gilead Sciences, Inc. (187.36B), less than Johnson & Johnson (595.44B), less than AbbVie Inc. (426.24B), less than Eli Lilly and Company (891.90B), greater than Pfizer Inc. (219.72B), greater than Amgen Inc. (232.96B),

CompanyEnterprise ValueMarket cap
305.10B$282.29B
92.40B$104.12B
265.57B$305.23B
153.99B$117.06B
107.73B$108.62B
318.27B$282.30B
187.36B$170.34B
595.44B$567.22B
426.24B$362.60B
891.90B$856.56B
219.72B$153.44B
232.96B$187.49B

Build a custom stock screener for AstraZeneca PLC (AZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AstraZeneca PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AstraZeneca PLC (AZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AstraZeneca PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AstraZeneca PLC's Enterprise Value?

What is the highest Enterprise Value for AstraZeneca PLC (AZN)?

What is the 3-year average Enterprise Value for AstraZeneca PLC (AZN)?

What is the 5-year average Enterprise Value for AstraZeneca PLC (AZN)?

How does the current Enterprise Value for AstraZeneca PLC (AZN) compare to its historical average?